Featured Posts
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing.
Search Posts
Op-Eds
Flu pandemic prevention
This month's outbreak of H5N1 avian flu in Turkey—as many as 50 human cases and several deaths—looks very like what we might see…
Products
Europe’s Global REACH: Chemical Regulations in Europe Promise Worldwide Costs
This month, the European Parliament voted in favor of a massive new expansion of the European Union's (EU) chemical regulations. Known as REACH—which stands for…
Products
The Tale of a Medical Device
Senator Hillary Clinton traveled 6,000 miles to dramatize the need for faster medical device approvals. Hard to believe, isn’t it? In fact, Sen. Clinton…
Products
Millennium Challenged? New Approach to Foreign Aid Threatens to Become More of the Same
Standing alongside U2 lead singer Bono in March 2002, President Bush announced the formation of a “new compact for global development, defined by new accountability.”…
Op-Eds
Cruel and Unusual: People for the Ethical Treatment of Animals
On January 9, two employees of the group People for the Ethical Treatment of Animals (PETA) will appear in court to answer felony…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. ENERGY A conflict between Ukraine and Russia threatens to undermine natural gas supplies to much of…